Echinacea

📜 Historical Use

Echinacea goes by echinacea, purple coneflower, coneflower and American coneflower, and is native to areas east of the Rocky Mountains in the United States. The E. purpurea species was originally discovered by Native Americans in North America, who used the plant medicinally for respiratory tract infections, tooth pain and snakebite. Of those three traditional indications only one reached the modern market: echinacea products are primarily promoted today as a dietary supplement for the common cold and other respiratory tract infections, based on the idea that certain species may stimulate the immune system. Tooth pain and snakebite quietly disappeared — a useful reminder that the surviving traditional use survived because it was commercially convenient, not because it was the one that was validated. A second modern branch has no traditional pedigree at all: some echinacea products are promoted for topical use on the skin for problems such as eczema, a use for which NCCIH says the evidence is unclear. The herb remains an active research subject rather than a settled one; recent NCCIH-funded work has included studies of the effects of echinacea on the immune system, and the 2016 finding that the plant's own bacterial community drives macrophage activation in the laboratory came out of that programme. Long continuous respiratory use is a real fact about echinacea. It is not, by itself, evidence that echinacea works.

📊 What the Research Shows

Echinacea is unusually well studied for a herbal supplement and the results are unusually unhelpful. Many studies have been done in people on echinacea for the common cold and other respiratory tract infections; much less on its other uses. NCCIH's conclusion splits the popular claim in two, and the half that survives is not the half that sells bottles. Taking echinacea may slightly reduce your chances of catching a cold. But it is still unclear whether echinacea can shorten the length of a cold — precisely what most packaging and most "take it at the first sign" advice promises. NCCIH adds that more research is needed to confirm even the prevention finding. At least 24 studies have tested echinacea for preventing colds or relieving cold symptoms, and a comprehensive 2014 assessment concluded echinacea has not been convincingly shown to be beneficial, though at least some products might have a weak effect. NCCIH's colds and flu fact sheet files echinacea where the evidence is "conflicting, inadequate, or mostly negative", alongside garlic and American ginseng — not in the group showing some promise, which is oral zinc, nasal rinsing, honey for nighttime cough in children, vitamin C under severe physical stress, probiotics and meditation. In children, one recent study found echinacea might reduce the chance of respiratory tract infection and associated complications, but overall there is not enough evidence to support a clear connection. For influenza, no complementary approach has been shown to prevent the flu or relieve flu symptoms. It is also unclear whether echinacea helps other conditions, including eczema, despite topical products being promoted for skin problems.

Take echinacea tincture or tea at first sign of cold. 3x daily for up to 10 days.

Do not use continuously over 8 weeks. Avoid with autoimmune conditions.

⚠️ What happens if taken in excess:

Prolonged continuous use (>10 days) may suppress rather than stimulate the immune system. Allergic reactions including anaphylaxis can occur, especially in those allergic to ragweed/daisies. High doses may cause nausea, stomach pain, and dizziness. Can worsen autoimmune conditions by stimulating immune activity. Rare cases of liver inflammation reported.

NCCIH names three interaction concerns and hedges all three; the hedges are the useful part. First, there is conflicting evidence about whether echinacea interacts with some drugs metabolized by the liver. NCCIH names no cytochrome P450 enzyme for echinacea, so this page will not either: any source telling you echinacea inhibits or induces CYP3A4 or CYP1A2 goes further than the federal fact sheet does, and the direction of such an effect would determine whether a co-administered drug's level rises or falls. Second, there are theoretical reasons to suspect echinacea might interact with immunosuppressants — a theory resting on the immune-stimulation premise NCCIH elsewhere calls unestablished, and naming no agent, so cyclosporine, tacrolimus and mycophenolate are not stated interactions but the obvious drugs to check against a pharmacology source. Third, and rarely mentioned on supplement pages, there are theoretical reasons to suspect an interaction with caffeine — worth flagging because echinacea is routinely taken with coffee or tea. Beyond those, NCCIH's general instruction applies: if you take any medicine, talk to your health care provider before using echinacea, because some herbs and medicines interact in harmful ways. One informative absence: on the same colds and flu fact sheet NCCIH warns that American ginseng may interact with the anticoagulant warfarin and that garlic may interact with anticoagulants, while raising no bleeding concern for echinacea. Absence of a documented interaction is not evidence of safety alongside a prescription, but the bleeding-risk warning pasted onto every herb does not come from this source.

1. Evaluation of echinacea for prevention and treatment of the common cold: a meta-analysis — Shah SA, Sander S, White CM et al Lancet Infect Dis (2007)[doi ↗]
2. Echinacea purpurea therapy for upper respiratory tract infections in children — Weber W et al J Altern Complement Med (2005)[PubMed ↗]
3. Echinacea — NCCIH — National Institutes of Health NCCIH (NIH) (2020)[NIH ↗]